325 related articles for article (PubMed ID: 28577308)
1. Empirical antibiotics targeting gram-positive bacteria for the treatment of febrile neutropenic patients with cancer.
Beyar-Katz O; Dickstein Y; Borok S; Vidal L; Leibovici L; Paul M
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD003914. PubMed ID: 28577308
[TBL] [Abstract][Full Text] [Related]
2. Empirical antibiotics targeting Gram-positive bacteria for the treatment of febrile neutropenic patients with cancer.
Paul M; Dickstein Y; Borok S; Vidal L; Leibovici L
Cochrane Database Syst Rev; 2014 Jan; (1):CD003914. PubMed ID: 24425445
[TBL] [Abstract][Full Text] [Related]
3. Additional anti-Gram-positive antibiotic treatment for febrile neutropenic cancer patients.
Paul M; Borok S; Fraser A; Vidal L; Cohen M; Leibovici L
Cochrane Database Syst Rev; 2005 Jul; (3):CD003914. PubMed ID: 16034915
[TBL] [Abstract][Full Text] [Related]
4. Early discontinuation of antibiotics for febrile neutropenia versus continuation until neutropenia resolution in people with cancer.
Stern A; Carrara E; Bitterman R; Yahav D; Leibovici L; Paul M
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012184. PubMed ID: 30605229
[TBL] [Abstract][Full Text] [Related]
5. Empirical antibiotics against Gram-positive infections for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials.
Paul M; Borok S; Fraser A; Vidal L; Leibovici L
J Antimicrob Chemother; 2005 Apr; 55(4):436-44. PubMed ID: 15722392
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia.
Paul M; Dickstein Y; Schlesinger A; Grozinsky-Glasberg S; Soares-Weiser K; Leibovici L
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD003038. PubMed ID: 23813455
[TBL] [Abstract][Full Text] [Related]
8. Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams.
Paul M; Yahav D; Bivas A; Fraser A; Leibovici L
Cochrane Database Syst Rev; 2010 Nov; 2010(11):CD005197. PubMed ID: 21069685
[TBL] [Abstract][Full Text] [Related]
9. Outpatient treatment for people with cancer who develop a low-risk febrile neutropaenic event.
Rivas-Ruiz R; Villasis-Keever M; Miranda-Novales G; Castelán-Martínez OD; Rivas-Contreras S
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD009031. PubMed ID: 30887505
[TBL] [Abstract][Full Text] [Related]
10. Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients.
Vidal L; Ben Dor I; Paul M; Eliakim-Raz N; Pokroy E; Soares-Weiser K; Leibovici L
Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD003992. PubMed ID: 24105485
[TBL] [Abstract][Full Text] [Related]
11. Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis.
Paul M; Lador A; Grozinsky-Glasberg S; Leibovici L
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003344. PubMed ID: 24395715
[TBL] [Abstract][Full Text] [Related]
12. Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients.
Vidal L; Paul M; Ben-Dor I; Pokroy E; Soares-Weiser K; Leibovici L
Cochrane Database Syst Rev; 2004 Oct; (4):CD003992. PubMed ID: 15495074
[TBL] [Abstract][Full Text] [Related]
13. Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.
Cortegiani A; Russotto V; Maggiore A; Attanasio M; Naro AR; Raineri SM; Giarratano A
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD004920. PubMed ID: 26772902
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy.
Gafter-Gvili A; Fraser A; Paul M; Vidal L; Lawrie TA; van de Wetering MD; Kremer LC; Leibovici L
Cochrane Database Syst Rev; 2012 Jan; 1(1):CD004386. PubMed ID: 22258955
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy.
Skoetz N; Bohlius J; Engert A; Monsef I; Blank O; Vehreschild JJ
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007107. PubMed ID: 26687844
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic antibiotics for preventing gram-positive infections associated with long-term central venous catheters in adults and children receiving treatment for cancer.
van den Bosch CH; van Woensel J; van de Wetering MD
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD003295. PubMed ID: 34617602
[TBL] [Abstract][Full Text] [Related]
17. Interventions for primary vesicoureteric reflux.
Williams G; Hodson EM; Craig JC
Cochrane Database Syst Rev; 2019 Feb; 2(2):CD001532. PubMed ID: 30784039
[TBL] [Abstract][Full Text] [Related]
18. Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis.
Paul M; Silbiger I; Grozinsky S; Soares-Weiser K; Leibovici L
Cochrane Database Syst Rev; 2006 Jan; (1):CD003344. PubMed ID: 16437452
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy.
Gafter-Gvili A; Fraser A; Paul M; van de Wetering M; Kremer L; Leibovici L
Cochrane Database Syst Rev; 2005 Oct; (4):CD004386. PubMed ID: 16235360
[TBL] [Abstract][Full Text] [Related]
20. Very early discharge versus early discharge versus non-early discharge in children with cancer and febrile neutropenia.
Loeffen EA; Te Poele EM; Tissing WJ; Boezen HM; de Bont ES
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD008382. PubMed ID: 26899263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
